Gilpin Wealth Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Gilpin Wealth Management's ASTH Position: Q2 2026 in Review
Gilpin Wealth Management increased its Astrana Health (ASTH) stake by 400% in Q2 2026, buying an estimated $144 and bringing the position to 5 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #881.
Gilpin Wealth Management first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Gilpin Wealth Management held 5 shares of Astrana Health worth $233 as of Q2 2026.
- Gilpin Wealth Management bought 4 Astrana Health shares in Q2 2026, an estimated $144.
- Astrana Health made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #881 holding.
- Gilpin Wealth Management first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
- 208 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.